NEXAVAR for Thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where NEXAVAR was used for Thyroid cancer.
Most Reported Side Effects for NEXAVAR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 46 | 12.6% | 14 | 18 |
| Hepatocellular carcinoma | 42 | 11.5% | 33 | 12 |
| Palmar-plantar erythrodysaesthesia syndrome | 36 | 9.9% | 16 | 11 |
| Hepatic cancer | 27 | 7.4% | 9 | 8 |
| Decreased appetite | 24 | 6.6% | 9 | 12 |
| Hypertension | 22 | 6.0% | 8 | 8 |
| Fatigue | 20 | 5.5% | 5 | 7 |
| Renal cancer | 20 | 5.5% | 1 | 0 |
| Rash | 19 | 5.2% | 6 | 6 |
| Abdominal pain | 18 | 4.9% | 4 | 10 |
| Nausea | 18 | 4.9% | 5 | 12 |
| Pain in extremity | 18 | 4.9% | 3 | 6 |
| Ascites | 17 | 4.7% | 10 | 12 |
| Death | 17 | 4.7% | 16 | 4 |
| Hepatic encephalopathy | 17 | 4.7% | 9 | 13 |
Other Indications for NEXAVAR
Hepatocellular carcinoma (141)
Hepatic cancer (103)
Renal cancer (29)
Renal cell carcinoma (16)
Metastases to lung (6)
Other Drugs Used for Thyroid cancer
LENVATINIB (2,668)
CABOZANTINIB S-MALATE (1,615)
VANDETANIB (591)
DABRAFENIB (583)
TRAMETINIB DIMETHYL SULFOXIDE (482)
SORAFENIB (399)
LEVOTHYROXINE (299)
PAZOPANIB (264)
PRALSETINIB (199)
CABOZANTINIB (125)